New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 9, 2014
08:09 EDTNPSPNPS Pharmaceuticals price target raised to $41 from $36 at Brean Capital
Brean Capital raised its price target on NPS Pharmaceuticals following yesterday's 2014 guidance. The firm believes its guidance is conservative and it will beat and raise its guidance over the course of the year. Shares are Buy rated.
News For NPSP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 24, 2014
08:12 EDTNPSPNPS Pharmaceuticals says Teduglutide granted orphan drug designation in Japan
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use